All sponsors

InSilico Medicine Hong Kong Limited

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS5
PHASE 3 / 2-31
RECRUITING5
READOUTS ≤12 MONTHS2
Open InSilico Medicine Hong Kong Limited on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
INS018_055
NCT05975983
P2RecruitingIdiopathic Pulmonary Fibrosis (IPF)402026-02-28
ISM5411 tablets
NCT07265570
P2RecruitingUlcerative Colitis802027-08-15
ISM6331
NCT06566079
P1/2RecruitingMalignant Mesothelioma; Metastatic Malignant Solid Tumor1602027-08-31
ISM3412
NCT06414460
P1/2RecruitingLocally Advanced/Metastatic Solid Tumors1462028-03-31
INS018_055 tablets
NCT07687459
P3RecruitingIdiopathic Pulmonary Fibrosis3202029-10-30